Developments in regulations ofgenome-editedplants are rapidly changing
and continue to evolve as more countries firm up their regulatory
policies. This is according to the/Transgenic Research/article authored
by international biotech experts.

The article presents the latest legal and regulatory developments in
various jurisdictions includingCanada, Argentina, Brazil, theUSA, Kenya,
Nigeria, South Africa, Australia, New Zealand, Japan, and
thePhillipines. Some of the key points in the article are as follows:

* Genome editing has the potential to contribute to saving several
challenges in health, food, and agricultural production.
* The regulatory policy cannot keep pace with the fast-moving
scientific advances.
* Scientific societies, regulatory agencies, and other relevant
organizations have investigated the issues surrounding genome
editing and concluded that imposing regulatory scrutiny based on
documented risks of the product, rather than on the process and that
products of genome editing, may not need additional regulation
required for conventional plants.
* Common approaches in regulation are emerging in many countries,
including the use of the "case-by-case" approach and "novel
combination of genetic material" as GMO regulatory threshold.

The authors, including Jon Entine, Martin Lema, Wayne Parrot, Carl
Ramage, Reynante Ordonio, and Diane Wray-Cahen, hope for increased
collaboration to better align regulatory processes and improve
coordination of approaches worldwide.

Regulatory approaches for genome edited agricultural plants in select
countries and jurisdictions around the world (springer.com)
[link.springer.com]